Épisodes

  • Cancer patient advocate reinforces importance of normalizing conversations about symptoms

    Cancer patient advocate reinforces importance of normalizing conversations about symptoms
    Dec 15 2025

    In this conversation, Margie Wilson talks to Fred Hutch Cancer Center's Bonnie Rochman about her experience being diagnosed with endometrial cancer and her evolution into a patient advocate for Black women. She discusses her initial symptoms and treatment, the challenges of navigating the medical system, and the importance of having open conversations about women's health and finding a supportive healthcare provider.

    • Margie was diagnosed with endometrial cancer in 2016 after experiencing unexplained bleeding that she attributed to menopause.
    • The first oncologist she saw was dismissive and rushed, but finding a compassionate and understanding doctor made a significant difference in her treatment experience.
    • Brachytherapy was a key part of her treatment plan.
    • Margie became involved with ECANA to advocate for Black women with endometrial cancer.
    • Education and awareness are vital in saving lives and improving health outcomes for women.
    Voir plus Voir moins
    21 min
  • CAR T-cell therapy with Dr. Mazyar Shadman

    CAR T-cell therapy with Dr. Mazyar Shadman
    Nov 25 2025

    Dr. Mazyar Shadman is a blood cancer specialist at Fred Hutch Cancer Center who focuses on lymphoid malignancies. In a conversation with Bonnie Rochman, they explore the advancements in CAR T-cell therapy, particularly for large B-cell lymphoma, highlighting its impact on patient outcomes and survival rates.

    Takeaways

    • CAR T therapy is a significant advancement in cancer treatment.
    • The future of cancer treatment may heavily rely on CAR T advancements.
    • CAR T therapy represents a shift in cancer care paradigms.
    • It is particularly effective for large B-cell lymphoma.
    • Patients with relapsed disease historically had limited survival chances.
    • CAR T therapy has improved outcomes for high-risk patients.
    • 30 to 40% of patients are now being cured with CAR T therapy.
    • The treatment offers better quality of life compared to standard care.
    • Ongoing research is crucial for further advancements in CAR T.
    • Patient selection is key for the success of CAR T therapy.
    Voir plus Voir moins
    16 min
  • Delivering the Best Possible Cancer Care with Tom Purcell

    Delivering the Best Possible Cancer Care with Tom Purcell
    Nov 5 2025

    In this conversation, Dr. Tom Purcell, Chief Medical Officer at Fred Hutch Cancer Center, discusses his role in overseeing quality care delivery and patient satisfaction with Bonnie Rochman. He reflects on his previous experience in a community cancer program and emphasizes the importance of a multidisciplinary team approach in optimizing patient care. The conversation also touches on the cultural shifts necessary for improving healthcare delivery and the ongoing efforts to enhance patient access and satisfaction.
    Voir plus Voir moins
    13 min
  • Frogs help Fred Hutch find the shape of small things

    Frogs help Fred Hutch find the shape of small things
    Oct 27 2025
    Frogs are back at Fred Hutch after a long absence to study the structure of DNA-linked molecular complexes that change during the cell cycle and malfunction in cancer and other diseases. Fred Hutch writer / editor John Higgins discusses his latest story on the current and past frog research with multimedia editor Robert Hood.
    Voir plus Voir moins
    8 min
  • The Message Is the Medium - David Patton and Robert Hood

    The Message Is the Medium - David Patton and Robert Hood
    Oct 22 2025

    After more than a decade of providing high-quality cancer and research stories via the Fred Hutch website, the organization is evolving its storytelling to go beyond the browser. David Patton, Fred Hutch's content strategy lead, talks with Heart of the Hutch producer and multimedia editor Robert Hood about this dynamic storytelling evolution. The goal is to reach audiences with the same high value cancer and science information in the platforms and formats they are now relying on more often. Learn more at FredHutch.com/News
    Voir plus Voir moins
    15 min
  • When work becomes personal - John Scheleen

    When work becomes personal - John Scheleen
    Sep 24 2025
    Welcome to Bench to Bedside and Beyond, stories from Fred Hutch Cancer Center about how our scientists and clinicians are combining innovative research with compassionate care to address the impact of cancer and infectious disease. You'll hear from patients, researchers, doctors, caregivers, supporters and others seeking to prevent and eliminate cancer. In this conversation, John Scheleen talks about his experience being treated for cancer for much of his tenure as a Fred Hutch employee with Bonnie Rochman, a writer for Fred Hutch News. Scheleen recounts how he found a "weird mole" that catapulted him out of the world of grants and financial reports and into the world of patient care. He recalls what it was like to wait for biopsy results during the weekend in which his son celebrated his first birthday, a time of anxiety and joy. And he explains that his work closing out grants is especially meaningful when he recognizes the names of providers who have treated him.
    Voir plus Voir moins
    11 min
  • Gratitude inspires a job search - Tiffany Bucklin

    Gratitude inspires a job search - Tiffany Bucklin
    Sep 24 2025
    Welcome to Bench to Bedside and Beyond, stories from Fred Hutch Cancer Center about how our scientists and clinicians are combining innovative research with compassionate care to address the impact of cancer and infectious disease. You'll hear from patients, researchers, doctors, caregivers, supporters and others seeking to prevent and eliminate cancer. In this conversation, Tiffany Bucklin talks about her unwavering commitment to getting a job at Fred Hutch after her husband was treated here for leukemia. She tells Bonnie Rochman, a writer for Fred Hutch News, how her husband's care team impressed her by remembering their children's names. Bucklin reflects on how it felt to have the team take a "vested interest in our story and how it ended."
    Voir plus Voir moins
    10 min
  • From guinea pig to long-term survivor - Chris Lundy

    From guinea pig to long-term survivor - Chris Lundy
    Sep 24 2025
    Welcome to Bench to Bedside and Beyond, stories from Fred Hutch Cancer Center about how our scientists and clinicians are combining innovative research with compassionate care to address the impact of cancer and infectious disease. You'll hear from patients, researchers, doctors, caregivers, supporters and others seeking to prevent and eliminate cancer. In this conversation, Chris Lundy tells Bonnie Rochman, a writer for Fred Hutch News, what it was like to be among the first wave of bone marrow transplant recipients. Lundy was 21 and in the military when he came to Fred Hutch in 1971 for a life-saving transplant. He recalls being told that he had a 10% chance of survival. More than 50 years later, he reflects on how he beat the odds in a big way.
    Voir plus Voir moins
    23 min